Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Identifying employed multiple sclerosis patients at-risk for job loss: When do negative work events pose a threat?
Acrolein-mediated conduction loss is partially restored by potassium channel blockers.
Discriminating long myelitis of neuromyelitis optica from sarcoidosis.
ACTH protects mature oligodendroglia from excitotoxic and inflammation-related damage in vitro.
Premature immune senescence in children with MS: Too young to go steady.
Severe Disability in Patients with Relapsing-Remitting Multiple Sclerosis Is Associated with Profound Changes in the Regulation of Leptin Secretion.
Comparing long-term results of PASAT and SDMT scores in relation to neuropsychological testing in multiple sclerosis.
New mutation in periaxin gene causing charcot marie tooth disease in a puerto rican young male.
Erratum to: Advancing drug delivery systems for the treatment of multiple sclerosis.
The feasibility and short-term benefits of Blue Prescription: a novel intervention to enable physical activity for people with multiple sclerosis.
Mean upper cervical cord area (MUCCA) measurement in long-standing multiple sclerosis: Relation to brain findings and clinical disability.
Therapeutic strategies in multiple sclerosis: A focus on neuroprotection and repair and relevance to schizophrenia.
[LINGO-1 Expression of brain tissue in Experimental Autoimmune Encephalomyelitis Mouse].
The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage.
Suppression of miR-155 Expression in IFN-γ-Treated Astrocytes and Microglia by DJ-1: A Possible Mechanism for Maintaining SOCS1 Expression.
Persistent visual impairment in multiple sclerosis: prevalence, mechanisms and resulting disability.
Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica.
Clinical and radiological features of recurrent demyelination following acute disseminated encephalomyelitis (ADEM).
Combining billing codes, clinical notes, and medications from electronic health records provides superior phenotyping performance.
CXXC5 plays a role as a transcription activator for myelin genes on oligodendrocyte differentiation.
Remyelination of the Corpus Callosum by Olfactory Ensheathing Cell in an Experimental Model of Multiple Sclerosis.
Treating prolactinoma can prevent autoimmune diseases.
ShcA Regulates Late Stages of T Cell Development and Peripheral CD4+ T Cell Numbers.
Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis.
Neuroplasticity and motor rehabilitation in multiple sclerosis.
Pages
« first
‹ previous
…
505
506
507
508
509
510
511
512
513
…
next ›
last »